Microbial inoculants show potential for remediating nitrate-rich, salinized soils. However, native strains often exhibit suboptimal performance under high-salinity and high-nitrate conditions, limiting their practical application. To develop a nitrate-reducing strain suitable for saline soil remediation, we adaptively acclimated a nitrate-reducing Bacillus velezensis strain BV-1 under high-nitrate conditions to enhance its salt tolerance and nitrogen metabolic capacity. The acclimatized strain exhibited significantly upregulated nar genes (4.71- to 7.56-fold) and nirD expression (1.36-fold), indicating enhanced nitrate assimilation and dissimilatory nitrate reduction to ammonium activity. In pot experiments, inoculation with this strain resulted in 46.85% nitrate removal, improved nutrient utilization (with increases of 21.86% in ammonium-N and 29.64% in available phosphorus utilization), and a 20.82% increase in lettuce fresh weight. These findings demonstrate that microbial acclimatization is an effective strategy for developing robust bioinoculants, with broad implications for sustainable agriculture and microbial strain engineering in salinized environments.
{"title":"Adaptive acclimatization yields a Bacillus velezensis strain with enhanced nitrate metabolism for remediating salinized soil","authors":"Puguo Hao, Junhua Xie, Mujin Guo, Yifan Zhang, Yunxiang Xu, Muyuan Wang, Yizhao Wu, Qi Zhao, Jibao Jiang, Yinsheng Li","doi":"10.1007/s10482-025-02183-9","DOIUrl":"10.1007/s10482-025-02183-9","url":null,"abstract":"<div><p>Microbial inoculants show potential for remediating nitrate-rich, salinized soils. However, native strains often exhibit suboptimal performance under high-salinity and high-nitrate conditions, limiting their practical application. To develop a nitrate-reducing strain suitable for saline soil remediation, we adaptively acclimated a nitrate-reducing <i>Bacillus velezensis</i> strain BV-1 under high-nitrate conditions to enhance its salt tolerance and nitrogen metabolic capacity. The acclimatized strain exhibited significantly upregulated <i>nar</i> genes (4.71- to 7.56-fold) and <i>nirD</i> expression (1.36-fold), indicating enhanced nitrate assimilation and dissimilatory nitrate reduction to ammonium activity. In pot experiments, inoculation with this strain resulted in 46.85% nitrate removal, improved nutrient utilization (with increases of 21.86% in ammonium-N and 29.64% in available phosphorus utilization), and a 20.82% increase in lettuce fresh weight. These findings demonstrate that microbial acclimatization is an effective strategy for developing robust bioinoculants, with broad implications for sustainable agriculture and microbial strain engineering in salinized environments.</p></div>","PeriodicalId":50746,"journal":{"name":"Antonie Van Leeuwenhoek International Journal of General and Molecular Microbiology","volume":"118 11","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145256690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-04DOI: 10.1007/s10482-025-02181-x
Haseeb Ahmed, Zain Ul Abideen, Ammar Azmat, Muhammad Irfan, Salman Anjum, Afaf Dirie
The COVID-19 pandemic affected the global healthcare delivery system, raising concerns about its influence on antimicrobial resistance (AMR). This systematic review and meta-analysis assessed the impact of the COVID-19 pandemic on the prevalence of MDR bacteria in different healthcare environments. A systematic search was carried out in PubMed-MEDLINE, Embase, Web of Science, BIOSIS, Scopus, and Google Scholar for articles published from December 2019 to January 2024. After screening 77 full-text studies, 28 studies were included in the analysis. The inclusion criteria included original human studies presenting MDR bacteria incidence before and during/after COVID-19 with reference to Carbapenem-resistant Acinetobacter baumannii, Carbapenem-resistant Enterobacteriaceae, Vancomycin Resistant Enterococci, Carbapenem-Resistant Pseudomonas aeruginosa, Methicillin-resistant Staphylococcus aureus, and Extended-Spectrum Beta-Lactamase-producing Enterobacteriaceae. The overall odds ratio (OR = 0.91, 95% CI: 0.70–1.17) indicates no significant change in the prevalence of multidrug-resistant (MDR) bacterial infection between the pre-COVID-19 and the COVID-19 period. There was no significant change in the prevalence of MRSA, ESBL, and VRE pre- and post-COVID. However, there was a significant reduction in the prevalence of CR-Ab, CRE, and CRPA pre- and during/after-COVID-19. MDR prevalence was significantly increased in Asia (18%) while it decreased slightly in North America (10.3%), showing variations in antibiotic use. The findings show that COVID-19 has different effects on the prevalence of MDR bacteria across geographical regions and healthcare facilities.
2019冠状病毒病大流行影响了全球医疗保健服务系统,引发了人们对其对抗菌素耐药性影响的担忧。本系统综述和荟萃分析评估了COVID-19大流行对不同医疗环境中耐多药细菌流行率的影响。系统检索2019年12月至2024年1月在PubMed-MEDLINE、Embase、Web of Science、BIOSIS、Scopus和谷歌Scholar中发表的文章。在筛选了77项全文研究后,有28项研究被纳入分析。纳入标准包括耐碳青霉烯鲍曼不动杆菌、耐碳青霉烯肠杆菌科、耐万古霉素肠球菌、耐碳青霉烯铜绿假单胞菌、耐甲氧西林金黄色葡萄球菌和广谱β -内酰胺酶产肠杆菌科在COVID-19之前和期间/之后出现耐多药细菌发生率的原始人类研究。总体优势比(OR = 0.91, 95% CI: 0.70-1.17)表明,在COVID-19前期和COVID-19期间,多药耐药(MDR)细菌感染的患病率没有显著变化。MRSA、ESBL和VRE的流行在covid前后没有显著变化。然而,在covid -19之前和期间/之后,CR-Ab、CRE和CRPA的患病率显著降低。耐多药流行率在亚洲显著增加(18%),而在北美略有下降(10.3%),显示出抗生素使用的差异。研究结果表明,COVID-19对不同地理区域和医疗机构的耐多药细菌流行率有不同的影响。
{"title":"Impact of COVID-19 on the prevalence of multi-drug-resistant bacteria: a literature review and meta-analysis","authors":"Haseeb Ahmed, Zain Ul Abideen, Ammar Azmat, Muhammad Irfan, Salman Anjum, Afaf Dirie","doi":"10.1007/s10482-025-02181-x","DOIUrl":"10.1007/s10482-025-02181-x","url":null,"abstract":"<div><p>The COVID-19 pandemic affected the global healthcare delivery system, raising concerns about its influence on antimicrobial resistance (AMR). This systematic review and meta-analysis assessed the impact of the COVID-19 pandemic on the prevalence of MDR bacteria in different healthcare environments. A systematic search was carried out in PubMed-MEDLINE, Embase, Web of Science, BIOSIS, Scopus, and Google Scholar for articles published from December 2019 to January 2024. After screening 77 full-text studies, 28 studies were included in the analysis. The inclusion criteria included original human studies presenting MDR bacteria incidence before and during/after COVID-19 with reference to <i>Carbapenem-resistant Acinetobacter baumannii</i>, <i>Carbapenem-resistant Enterobacteriaceae</i>, <i>Vancomycin Resistant Enterococci</i>, <i>Carbapenem-Resistant Pseudomonas aeruginosa</i>, <i>Methicillin-resistant Staphylococcus aureus,</i> and <i>Extended-Spectrum Beta-Lactamase</i>-producing <i>Enterobacteriaceae</i>. The overall odds ratio (OR = 0.91, 95% CI: 0.70–1.17) indicates no significant change in the prevalence of multidrug-resistant (MDR) bacterial infection between the pre-COVID-19 and the COVID-19 period. There was no significant change in the prevalence of <i>MRSA</i>, <i>ESBL</i>, and <i>VRE</i> pre- and post-COVID. However, there was a significant reduction in the prevalence of <i>CR-Ab</i>, <i>CRE</i>, and <i>CRPA</i> pre- and during/after-COVID-19. MDR prevalence was significantly increased in Asia (18%) while it decreased slightly in North America (10.3%), showing variations in antibiotic use. The findings show that COVID-19 has different effects on the prevalence of MDR bacteria across geographical regions and healthcare facilities.</p></div>","PeriodicalId":50746,"journal":{"name":"Antonie Van Leeuwenhoek International Journal of General and Molecular Microbiology","volume":"118 11","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145210536","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The anti-inflammatory, antioxidant properties of many probiotic microbes and their ability to modulate the composition of intestinal flora suggest that they have the potential to prevent and/or treat nonalcoholic fatty liver disease (NAFLD). The present study provides evidence that Lactiplantibacillus plantarum HP-B1280 can significantly reduce fat accumulation and inflammatory cell infiltration within the hepatocytes of fatty liver mice and thus may have potential application value in the prophylaxis and treatment of NAFLD disease. HP-B1280 also exhibits an extremely high level of resistance to acids and bile salts. The fermentation broth of HP-B1280 cultures is effectively suppresses the growth of a variety of common human pathogens. A comprehensive analysis of the complete genome sequence of L. plantarum HP-B1280 was conducted. Results indicated that the genome of L. plantarum HP-B1280 was devoid of resistance genes, drug resistance genes, as well as virulence factors. The annotation of the genome provides a foundation for further studies on the mechanism underlying the prevention and treatment of NAFLD by L. plantarum HP-B1280. In summary, the findings of the present study provides valuable insights into the potential use of probiotics, such as L. plantarum HP-B1280 in the amelioration and prophylaxis of NAFLD.
许多益生菌微生物的抗炎、抗氧化特性及其调节肠道菌群组成的能力表明,它们具有预防和/或治疗非酒精性脂肪性肝病(NAFLD)的潜力。本研究证明植物乳杆菌HP-B1280能显著减少脂肪肝小鼠肝细胞内脂肪堆积和炎症细胞浸润,在NAFLD疾病的预防和治疗中具有潜在的应用价值。HP-B1280对酸和胆盐也有极高的抵抗力。HP-B1280培养物的发酵液能有效抑制多种常见人类病原体的生长。对植物L. plantarum HP-B1280的全基因组序列进行了综合分析。结果表明,植物L. plantarum HP-B1280基因组缺乏耐药基因、耐药基因和毒力因子。该基因组的注释为进一步研究植物l.s plantarum HP-B1280防治NAFLD的机制奠定了基础。总之,本研究的发现为益生菌如植物乳杆菌HP-B1280在改善和预防NAFLD中的潜在应用提供了有价值的见解。
{"title":"The discovery, probiotic properties, and genome analysis of Lactiplantibacillus plantarum HP-B1280 with potential therapeutic application for the treatment of non-alcoholic fatty liver disease","authors":"Wei-Chen Liu, Meng-Jie Liu, Jin-Xiu Jiang, Bing-Yu Ma, Zheng-Jun Ma, Shao-Yang Hou, Hang Wu","doi":"10.1007/s10482-025-02179-5","DOIUrl":"10.1007/s10482-025-02179-5","url":null,"abstract":"<div><p>The anti-inflammatory, antioxidant properties of many probiotic microbes and their ability to modulate the composition of intestinal flora suggest that they have the potential to prevent and/or treat nonalcoholic fatty liver disease (NAFLD). The present study provides evidence that <i>Lactiplantibacillus plantarum</i> HP-B1280 can significantly reduce fat accumulation and inflammatory cell infiltration within the hepatocytes of fatty liver mice and thus may have potential application value in the prophylaxis and treatment of NAFLD disease. HP-B1280 also exhibits an extremely high level of resistance to acids and bile salts. The fermentation broth of HP-B1280 cultures is effectively suppresses the growth of a variety of common human pathogens. A comprehensive analysis of the complete genome sequence of <i>L. plantarum</i> HP-B1280 was conducted. Results indicated that the genome of <i>L. plantarum</i> HP-B1280 was devoid of resistance genes, drug resistance genes, as well as virulence factors. The annotation of the genome provides a foundation for further studies on the mechanism underlying the prevention and treatment of NAFLD by <i>L. plantarum</i> HP-B1280. In summary, the findings of the present study provides valuable insights into the potential use of probiotics, such as <i>L. plantarum</i> HP-B1280 in the amelioration and prophylaxis of NAFLD.</p></div>","PeriodicalId":50746,"journal":{"name":"Antonie Van Leeuwenhoek International Journal of General and Molecular Microbiology","volume":"118 11","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145208476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cordyceps militaris is a rare and highly valued medicinal fungus that has attracted considerable attention due to its production of diverse bioactive compounds, including nucleosides such as cordycepin, polysaccharides, lovastatin, carotenoids, etc., all of which exhibit significant nutritional and therapeutic potential. However, the large-scale utilization of C. militaris is constrained by several critical challenges. A major limitation is the progressive degeneration of strains over successive subcultures, which adversely affects fruiting body formation and metabolite biosynthesis. Moreover, genetic instability during long-term culture, contamination risks in large-scale production, and the lack of standardized cultivation and extraction protocols often result in variable product quality. The absence of efficient genetic transformation systems and the low success rate of genome editing approaches further complicate efforts in molecular strain improvement. This review provides a comprehensive overview of the principal bioactive compounds produced by C. militaris and critically evaluates the current challenges and limitations associated with both conventional and advanced strain improvement strategies. These include conventional approaches such as mutagenesis and protoplast fusion, as well as genome-editing technologies like CRISPR/Cas9, which are employed to enhance the biosynthesis of target metabolites. Moreover, the integration of metabolic engineering frameworks offers significant potential for rational strain design, optimization of bioprocesses, and the discovery of novel therapeutic agents.